What is the most common side effect of imatinib?

The “biggest” or most common side effect reported by nearly 60% to 90% of patients is Fluid Retention (Edema).

Side Effect	Incidence	Technical Rationale
Fluid Retention (Edema)	60% – 90%	Technically caused by the inhibition of PDGFR (Platelet-Derived Growth Factor Receptor), which regulates interstitial fluid pressure.
Gastrointestinal Upset	~50%	Nausea, vomiting, and diarrhea are frequent, likely due to direct mucosal irritation by the mesylate salt.
Muscle Cramps & Bone Pain	~40%	Linked to shifts in intracellular calcium and phosphate levels caused by the kinase inhibition.

As a manufacturer at Healthy Inc, your product inserts must specifically mention the patterns of this fluid retention:

Periorbital Edema: This is a “hallmark” of Imatinib—swelling specifically around the eyes, often most noticeable in the morning.
Peripheral Edema: Swelling of the ankles and feet.
Serious Risks: In rare cases, this can escalate to pleural effusion (fluid in the lungs) or pericardial effusion, requiring immediate medical intervention.

To maintain high “Brand Loyalty” for your oncology range, I recommend these technical tips for your B2B clients:

The “Water & Food” Rule: Nausea is significantly reduced if the 400 mg dose is taken with a large meal and a full glass ( $200\text{ ml}$ ) of water.
Salt Restriction: Patients experiencing edema should be advised to reduce dietary sodium intake.
Dosing Time: If nausea is severe, taking the dose before bed (with a snack) can help the patient “sleep through” the peak GI irritation.

From the CEO’s desk at Healthy Life Pharma / Healthy Inc:

The “Mesylate Salt” Stability: In our Mumbai facility, we ensure the Imatinib Mesylate is formulated to minimize “free acid” levels, which helps reduce the severity of gastric side effects.
Polymorph Control: We use the $\beta$ -crystalline form. While the $\alpha$ -form is easier to manufacture, the $\beta$ -form is technically more stable and has a more predictable dissolution profile, leading to fewer “spike” side effects in the patient.
B2B Value-Add: On your digital platforms, don’t just sell the tablet. Provide a “Support Kit” for B2B buyers that includes a patient diary for tracking weight (to monitor fluid retention) and muscle cramp management tips. This positions you as a Value-Added Manufacturer.
Packaging: We use Alu-Alu blisters to prevent any moisture ingress. Moisture can technically degrade the tablet’s integrity, leading to a faster release in the stomach and worse nausea.